These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14657164)

  • 1. Cannabinoids decrease corticostriatal synaptic transmission via an effect on glutamate uptake.
    Brown TM; Brotchie JM; Fitzjohn SM
    J Neurosci; 2003 Dec; 23(35):11073-7. PubMed ID: 14657164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum.
    Gerdeman G; Lovinger DM
    J Neurophysiol; 2001 Jan; 85(1):468-71. PubMed ID: 11152748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons.
    Huang CC; Lo SW; Hsu KS
    J Physiol; 2001 May; 532(Pt 3):731-48. PubMed ID: 11313442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.
    Köfalvi A; Rodrigues RJ; Ledent C; Mackie K; Vizi ES; Cunha RA; Sperlágh B
    J Neurosci; 2005 Mar; 25(11):2874-84. PubMed ID: 15772347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced striatal glutamate release after the administration of rimonabant to 6-hydroxydopamine-lesioned rats.
    García-Arencibia M; Ferraro L; Tanganelli S; Fernández-Ruiz J
    Neurosci Lett; 2008 Jun; 438(1):10-3. PubMed ID: 18457923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute D-amphetamine.
    Polissidis A; Chouliara O; Galanopoulos A; Naxakis G; Papahatjis D; Papadopoulou-Daifoti Z; Antoniou K
    Behav Brain Res; 2014 Aug; 270():261-9. PubMed ID: 24867330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta.
    Freestone PS; Guatteo E; Piscitelli F; di Marzo V; Lipski J; Mercuri NB
    Neuropharmacology; 2014 Apr; 79():467-75. PubMed ID: 24334069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterologous modulation of inhibitory synaptic transmission by metabotropic glutamate receptors in cultured hippocampal neurons.
    Fitzsimonds RM; Dichter MA
    J Neurophysiol; 1996 Feb; 75(2):885-93. PubMed ID: 8714661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
    Cadogan AK; Alexander SP; Boyd EA; Kendall DA
    J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal adenosine-cannabinoid receptor interactions in rats over-expressing adenosine A2A receptors.
    Chiodi V; Ferrante A; Ferraro L; Potenza RL; Armida M; Beggiato S; Pèzzola A; Bader M; Fuxe K; Popoli P; Domenici MR
    J Neurochem; 2016 Mar; 136(5):907-17. PubMed ID: 26526685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse.
    Pisani A; Calabresi P; Centonze D; Bernardi G
    Neuropharmacology; 1997 Jun; 36(6):845-51. PubMed ID: 9225312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatodendritic release of glutamate regulates synaptic inhibition in cerebellar Purkinje cells via autocrine mGluR1 activation.
    Duguid IC; Pankratov Y; Moss GW; Smart TG
    J Neurosci; 2007 Nov; 27(46):12464-74. PubMed ID: 18003824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus.
    Zheng L; Wu X; Dong X; Ding X; Song C
    Alcohol Clin Exp Res; 2015 Oct; 39(10):1908-16. PubMed ID: 26343919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of group I mGlu receptors antagonist with dopaminergic agonists strengthens the synaptic transmission at corticostriatal synapses in culture.
    Burguière A; De Bundel D; Valjent E; Roger J; Smolders I; Fagni L; Perroy J
    Neuropharmacology; 2013 Mar; 66():151-7. PubMed ID: 22465815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-synaptic adenosine A2A receptors control cannabinoid CB1 receptor-mediated inhibition of striatal glutamatergic neurotransmission.
    Martire A; Tebano MT; Chiodi V; Ferreira SG; Cunha RA; Köfalvi A; Popoli P
    J Neurochem; 2011 Jan; 116(2):273-80. PubMed ID: 21062287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms for synapse specificity during striatal long-term depression.
    Singla S; Kreitzer AC; Malenka RC
    J Neurosci; 2007 May; 27(19):5260-4. PubMed ID: 17494712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission.
    Ferreira SG; Gonçalves FQ; Marques JM; Tomé ÂR; Rodrigues RJ; Nunes-Correia I; Ledent C; Harkany T; Venance L; Cunha RA; Köfalvi A
    Br J Pharmacol; 2015 Feb; 172(4):1074-86. PubMed ID: 25296982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of group II metabotropic glutamate receptors inhibits glutamatergic transmission in the rat entorhinal cortex via reduction of glutamate release probability.
    Wang S; Chen X; Kurada L; Huang Z; Lei S
    Cereb Cortex; 2012 Mar; 22(3):584-94. PubMed ID: 21677028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures.
    Kim DJ; Thayer SA
    Brain Res; 2000 Jan; 852(2):398-405. PubMed ID: 10678767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CB1 receptor antagonism impairs the induction of epileptiform activity by group I metabotropic glutamate receptor activation.
    Karr L; Pan YZ; Rutecki PA
    Epilepsia; 2010 Jul; 51 Suppl 3(Suppl 3):121-5. PubMed ID: 20618416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.